General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
I have read claims that B12 is a general detoxifier but there is limited research supporting its direct action as a detoxifer
Yes, although rare, allergic reactions like rash, itching, or swelling can occur
Some content is produced with paid support from a third party, however our editorial decisions remain independent
For a good evaluation, it is essential to follow this rule: DO NOT TRY TO REMEMBER WHAT YOUR SYMPTOMS WERE SIX MONTHS AGO, OR EVEN LONGER
Preservative-Free Formulation: Ensures safety, especially for sensitive applications, by providing a preservative-free solution